CPSC recall 14229 — GSK Recalls Panadol Advance Bottles Due to Failure to Meet Child-Resistant Closure Requirement; Sold Exclusively in Puerto Rico

GSK Recalls Panadol Advance Bottles Due to Failure to Meet Child-Resistant Closure Requirement; Sold Exclusively in Puerto Rico

CPSC · 14229 · published 2014-07-14

CPSC campaign 14229

Hazard

The packaging is not child-resistant as required by the Poison Prevention Packaging Act. These products contain acetaminophen which is required by the Poison Prevention Packaging Act to be sealed with child-resistant packaging.

Remedy

Consumers should immediately place the product out of a child's sight and reach, and contact GSK for a refund.

The text above is quoted verbatim from the CPSC record. Confirm the affected units and the remedy with the manufacturer or CPSC. Recall data may be incomplete, delayed, or superseded.

Own something like this?

Track your items and we’ll tell you the moment a recall covers one — free, forever.

Track an item like this

Affected products

GlaxoSmithKline (GSK), of Moon Township, Penn.

Panadol Advance® 100 count caplets

GSK Recalls Panadol Advance Bottles Due to Failure to Meet Child-Resistant Closure Requirement; Sold Exclusively in Puerto Rico

Affected products

Brands in this recall